Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Controlled Clinical Trials

• Publication date

  1988-03-01

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1016/0197-2456(88)90007-4PMID 3356151
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysing changes in the presence of informative right censoring caused by death and withdrawal.

  1988cited by this paper
• Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process

  1988cited by this paper
• Empirical Bayes Estimation of Rates in Longitudinal Studies

  1983cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• A multivariate correction for attenuation

  1975cited by this paper
• Planning a longitudinal study. II. Frequency of measurement and study duration.

  1973cited by this paper

• Sample size calculation for randomized trials via inverse probability of response weighting when outcome data are missing at random

  2023cites this paper
• Mixed-Effects Negative Binomial Regression with Interval Censoring: A Simulation Study and Application to Aridity and All-Cause Mortality Among Black South Africans Over 1997–2013

  2021cites this paper
• Clustered Study Designs: Power Analysis

  2018cites this paper
• Power and sample size calculations for evaluating mediation effects in longitudinal studies

  2016cites this paper
• A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data

  2015cites this paper
• Sample sizes in dosage investigational clinical trials: a systematic evaluation

  2015cites this paper
• The Influence of Biostatistics at the National Heart, Lung, and Blood Institute

  2015cites this paper
• Responsiveness of the motor function measure in patients with spinal muscular atrophy.

  2013cites this paper
• Slope estimation of covariates that influence renal outcome following renal transplant adjusting for informative right censoring

  2012cites this paper
• Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE

  2011cites this paper
• Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

  2008cites this paper
• Power analyses for longitudinal study designs with missing data

  2007cites this paper
• Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.

  2006cites this paper
• Power analyses for correlations from clustered study designs

  2006cites this paper
• Rule‐of‐thumb adjustment of sample sizes to accommodate dropouts in a two‐stage analysis of repeated measurements

  2006cites this paper
• K‐Sample Test and Sample Size Calculation for Comparing Slopes in Data with Repeated Measurements

  2004cites this paper
• Power analyses for longitudinal trials and other clustered designs

  2004cites this paper
• Exact sample size determination in a weibull test plan when there is time censoring

  2003cites this paper
• Diabetic nephropathy. Aspects of pathophysiology and treatment.

  2003cites this paper
• Guidelines for the design of clinical trials with longitudinal outcomes.

  2002cites this paper
• Sample size calculations for randomized controlled trials.

  2002cites this paper
• Sample size calculations based on slopes and other summary statistics.

  1998cites this paper
• Design of HIV viral dynamics studies.

  1998cites this paper
• Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.

  1995cites this paper
• Sample size estimation using repeated measurements on biomarkers as outcomes.

  1994cites this paper
• A registry of patients with severe deficiency of alpha 1-antitrypsin. Design and methods. The Alpha 1-Antitrypsin Deficiency Registry Study Group.

  1994cites this paper
• A registry of patients with severe deficiency of alpha1-antitrypsin: Design and methods

  1994cites this paper
• Design aspects for clinical trials with repeated measures in the presence of informative censoring

  1994cites this paper
• Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease.

  1993cites this paper
• Time-period effects in longitudinal studies measuring average rates of change.

  1993cites this paper
• Methods for the analysis of informatively censored longitudinal data.

  1992cites this paper
• An experimental model for the study of thermochemotherapy in vivo.

  1992cites this paper
• A decade of progress in statistical methodology for clinical trials.

  1991cites this paper
• Design issues for a breast cancer chemoprevention trial.

  1991cites this paper
• Sample size calculations for two-group repeated-measures experiments

  1991cites this paper
• Early methodological developments for clinical trials at the National Heart, Lung and Blood Institute.

  1990cites this paper